Literature DB >> 2673803

Comparison of the effects of endothelin-1 and endothelin-3 on the rat stomach.

J L Wallace1, C M Keenan, W K MacNaughton, G W McKnight.   

Abstract

The effects of systemic administration of endothelin-1 and endothelin-3 on the susceptibility of the stomach to injury were compared in the anesthetized rat, as were their effects on gastric vascular tone, systemic blood pressure and hematocrit. When infused at concentrations in the 10(-7)-10(-6) M range, endothelin-1 was a far more potent hypertensive agent than endothelin-3. Endothelin-1 caused significant hemoconcentration, while endothelin-3 did not Endothelin-1 was approximately 5- to 10-times more potent as a vasoconstrictor in the stomach and a similar difference in potencies was observed when the ability of these peptides to increase the susceptibility of the stomach to ethanol-induced damage was compared. The two peptides were equipotent in producing gastric mucosal hemorrhage in the absence of any exogenous irritant. These results demonstrate that like endothelin-1, endothelin-3 has ulcerogenic and vasoconstriction actions in the stomach. While there are very large differences in the potencies of the two peptides in terms of producing systemic hypertension and hemoconcentration, the differences in the potency of the gastric ulcerogenic and vasoconstrictor effects are much less marked.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673803     DOI: 10.1016/0014-2999(89)90745-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  Endothelins. Vascular actions and clinical implications.

Authors:  T Sakurai; K Goto
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

Review 2.  Thirteenth Gaddum Memorial Lecture. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance.

Authors:  B J Whittle
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

3.  Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro.

Authors:  P D'Orléans-Juste; S Télémaque; A Claing
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

4.  Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.

Authors:  G H Allcock; T D Warner; J R Vane
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  Gastric functions in portal hypertension. Role of endothelin.

Authors:  O Günal; C Yeğen; A O Aktan; R Yalin; B C Yeğen
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

6.  Pharmacological characterization of endothelin receptors-mediated contraction in the mouse isolated proximal and distal colon.

Authors:  Humaira Khan; Robert J Naylor; Bishwa R Tuladhar
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

7.  A maxi Cl- channel coupled to endothelin B receptors in the basolateral membrane of guinea-pig parietal cells.

Authors:  H Kajita; T Kotera; Y Shirakata; S Ueda; M Okuma; K Oda-Ohmae; M Takimoto; Y Urade; Y Okada
Journal:  J Physiol       Date:  1995-10-01       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.